Navigation Links
Broadstreet Names Dorian Fabio Executive Vice President of Learning and Performance Improvement

Leading Healthcare Training and Marketing Consultant brings over 25 years of experience to help Broadstreet clients design and deliver more effective education and leadership programs.

NEW YORK, Feb. 10 /PRNewswire/ -- Creative marketing and communications agency Broadstreet today announced the appointment of Dorian S. Fabio as Executive Vice President of Learning and Performance Improvement. Fabio joins Broadstreet after years as a leading industry consultant. As founder of Putnam Scientific, Fabio provided scientific/technical product support for the development of educational programs directed to both physicians and pharmaceutical sales representatives, including advanced training for specialty sales forces. Having launched over 70 major pharmaceutical products both domestically and internationally, Dorian has developed both live and digital marketing and training programs for many of the world's leading pharmaceutical and biotech organizations including AstraZeneca (US and UK), Boehringer Ingelheim (US and Europe) Bristol-Myers Squibb, Forest Laboratories, GlaxoSmithKline, Janssen (US and International), Merck, Novartis (US and Europe), Ortho-McNeil, Pfizer (US and International), Roche Pharmaceuticals, sanofi-aventis. In her new role, Dorian will lead the Learning and Performance Improvement Group helping to create exceptional experiences for Broadstreet clients with their training and leadership development initiatives.

"Dorian is a powerful addition to the Broadstreet team," said Mark Baltazar, CEO and Managing Partner of Broadstreet. "Her expertise in adult learning combined with deep insights of new tools, technologies and techniques that enable greater retention provide our clients with a multi-talented resource to gain greater results from their sales training and leadership development programs."

Across her career, Dorian has led the creation of marketing and training programs for sales representatives, developed ACCME approved medical educational materials for physicians and pharmacists and served as the chief Strategist and Training Director for many of her clients. She founded Sciens Worldwide Medical Education where she was President and COO as well as the healthcare consultancy, The Exeter Group.

"Broadstreet excels at identifying the core cultural, business and brand elements within an organization then uses those insights to create effective training programs delivered across live and digital environments," commented Fabio. "This strategic approach has enabled Broadstreet to create exceptional learning and performance improvement experiences across a wide range of industries. Together we will provide our clients even more novel and innovative approaches to employee effectiveness and engagement."


Broadstreet is a marketing and communication agency that designs, develops and delivers strategy, creative and production for meeting and events, websites and social networks, video, print and learning and performance improvement programs for both internal and external audiences. Broadstreet clientele span the Global Fortune 500 with a concentration in the financial, pharmaceutical, entertainment|media, consumer, technology and hospitality sectors. Broadstreet has been named on the "Top" list of many publications for several years in a row.

SOURCE Broadstreet
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RoundTable Healthcare Partners Names Sandy Thompson as Senior Transaction Advisor
2. Herbalife Names Managing Director of Its South America Region
3. AMERIGROUP Names Finley Chief Compliance Officer
4. Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary
5. Elite Meetings International Names New Advisory Board
6. Kurt Salmon Associates Names John Karonis President of Retail and Consumer Products Group
7. Serotek Names Vision Australia Its Primary Reseller in Australia
8. Hospital Association Names New Chairman, Appoints Board Officers and New Members
9. Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
10. CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO
11. SynCare Names Gloria Payne Vice President - Medical Management
Post Your Comments:
(Date:11/29/2015)... ... ... Effective immediately, every single IguanaMed scrub style will be available at Target via ... “Buy One Scrub Set, Get the 2nd Scrub Set 50% Off” for a limited ... price. , IguanaMed’s mission is to outfit every healer around the world ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Safe storage for ... of two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, ... patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often than ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again ... choose from, the possibilities are endless. Users have full control over angle of view, ... masking effects, users are sure to get heads to turn. , ProPanel: Pulse offers ...
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 6th ... the University of British Columbia suggested that laws requiring bicyclists to wear helmets may ... part of the reason for the controversial conclusion is that, while helmets have certainly ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology: